Non-Current Assets
Operating Lease Right-of-Use Assets in Other Assets
West Pharmaceutical Services Operating Lease Right-of-Use Assets in Other Assets decreased by 5.8% to $110.20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 6.6%, from $103.40M to $110.20M. Over 5 years (FY 2020 to FY 2025), Operating Lease Right-of-Use Assets in Other Assets shows an upward trend with a 11.4% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
First reportedQ4 2018
Last reportedQ1 2026
Metric ID:
operating_lease_rou_assets_in_otherHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $62.80M | $58.50M | $69.30M | $75.60M | $76.90M | $86.60M | $104.40M | $101.10M | $99.20M | $96.80M | $99.20M | $96.80M | $110.30M | $108.00M | $104.50M | $103.40M | $104.40M | $97.80M | $117.00M | $110.20M |
| QoQ Change | — | -6.8% | +18.5% | +9.1% | +1.7% | +12.6% | +20.6% | -3.2% | -1.9% | -2.4% | +2.5% | -2.4% | +13.9% | -2.1% | -3.2% | -1.1% | +1.0% | -6.3% | +19.6% | -5.8% |
| YoY Change | — | — | — | — | +22.5% | +48.0% | +50.6% | +33.7% | +29.0% | +11.8% | -5.0% | -4.3% | +11.2% | +11.6% | +5.3% | +6.8% | -5.3% | -9.4% | +12.0% | +6.6% |
Range$58.50M – $117.00M
CAGR+12.6%
Avg YoY Growth+14.1%
Median YoY Growth+11.4%
Operating Lease Right-of-Use Assets in Other Assets at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's operating lease right-of-use assets in other assets?
- West Pharmaceutical Services (WST) reported operating lease right-of-use assets in other assets of $110.20M in Q1 2026.
- How has West Pharmaceutical Services's operating lease right-of-use assets in other assets changed year-over-year?
- West Pharmaceutical Services's operating lease right-of-use assets in other assets increased by 6.6% year-over-year, from $103.40M to $110.20M.
- What is the long-term trend for West Pharmaceutical Services's operating lease right-of-use assets in other assets?
- Over 5 years (2020 to 2025), West Pharmaceutical Services's operating lease right-of-use assets in other assets has grown at a 11.4% compound annual growth rate (CAGR), from $68.30M to $117.00M.